Doctors say children and teenagers with obesity are increasingly being seen with insulin resistance, fatty liver disease and ...
A new study is raising questions about whether people taking GLP-1 medications for obesity and diabetes could face a higher ...
Incretin therapies function by mimicking natural intestinal hormones like glucagon-like peptide-1 (GLP-1), which enhance ...
The World Health Organization (WHO) has issued its first-ever global guidelines for managing childhood obesity.
The new WHO recommendations ignore one of Robert F. Kennedy Jr.'s biggest priorities.
No weight-loss drugs or bariatric surgery for under-10s, WHO says in first global obesity guidelines
In 2024, an estimated 170 million children and adolescents aged 5–19 years were living with obesity, including 70 million ...
Eli Lilly and Company stocks have been trading up by 4.14 percent after bullish coverage spotlighted its obesity drug ...
No. 54 / 2026 Zealand Pharma announces positive Phase 2 ZUPREME-2 topline results for amylin analog petrelintide in people ...
The department was selected to lead the Purchase region’s Rural Community Hub, part of Kentucky’s Rural Health Transformation ...
Glucagon-like peptide-1 receptor agonists improve obstructive sleep apnea outcomes in obesity, primarily through significant weight loss.
The number of obese children has quadrupled since 1990 prompting the WHO to take action by issuing treatment guidelines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results